Overview

Topotecan and Melphalan for Retinoblastoma

Status:
Recruiting
Trial end date:
2027-12-30
Target enrollment:
Participant gender:
Summary
The purpose of this study is to evaluate topotecan and melphalan for retinoblastoma patients.
Phase:
Phase 3
Details
Lead Sponsor:
Sun Yat-sen University
Treatments:
Melphalan
Topotecan